Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Mount Airy › NPI 1366449282
Supplier

Northern Hospital District of Surry County

Northern Hospital District of Surry County was paid $16.42M by Medicaid between Jan 2018 and Dec 2024, across 151 billing codes. Its largest line is 99284, emergency room visit (serious) — 14% of everything it billed.

33Billing provider infoNORTHERN HOSPITAL DISTRICT OF SURRY COUNTY
MOUNT AIRY, NC 27030
33aNPI1366449282assigned 07/07/2005
33bProvider typeLong Term Care Pharmacy
28Total paid$16.42M
24GClaims636,016
24DCodes billed151
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Long Term Care Pharmacy providers in North Carolina

Rank by total paid#1 of 14
Median peer was paid$633.47
This provider vs. median25,925×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201897,984$1.59M
2019109,671$1.85M
202073,529$1.39M
202180,224$2.29M
202287,132$2.56M
2023102,636$3.37M
2024incomplete84,840$3.38M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 18,020 15,898 $2.22M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 27,426 24,529 $1.89M
74177 Computed tomography, abdomen and pelvis; with contrast material 11% 4,711 4,025 $1.76M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.7% 18,779 17,221 $1.11M
70450 Computed tomography, head or brain; without contrast material 5.3% 4,976 4,281 $870K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.1% 4,702 3,969 $843K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5.0% 38,536 34,796 $824K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4.2% 21,683 19,058 $682K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3.6% 14,048 11,570 $599K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.0% 6,161 5,525 $495K
96361 Intravenous infusion, hydration; each additional hour 3.0% 4,645 3,874 $486K
0202U Oncology (prostate), multianalyte, gene expression profiling 2.7% 3,763 3,354 $439K
139 more codes
87428 2.0% 4,548 $321K
71045 Radiologic examination, chest; single view 1.9% 17,315 $313K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.8% 24,408 $304K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.6% 6,446 $256K
80053 Comprehensive metabolic panel 1.4% 38,435 $229K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.3% 19,459 $210K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.1% 39,129 $184K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.1% 12,371 $173K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1.0% 9,073 $170K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 11,271 $158K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 1,336 $137K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 710 $130K
96375 Therapeutic injection; each additional sequential IV push <1% 4,930 $97K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,679 $83K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,562 $78K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 15,628 $78K
71275 Computed tomographic angiography, chest, with contrast material <1% 450 $75K
84484 <1% 16,285 $73K
71046 Radiologic examination, chest; 2 views <1% 1,961 $57K
87081 <1% 7,672 $53K
81001 <1% 24,342 $53K
83690 <1% 12,066 $52K
J3490 Unclassified drugs <1% 21,108 $50K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 991 $47K
36415 Collection of venous blood by venipuncture <1% 33,841 $45K
84443 Thyroid stimulating hormone (TSH) <1% 5,879 $44K
82550 <1% 15,217 $44K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,887 $41K
82553 <1% 8,750 $40K
36000 <1% 3,721 $35K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,494 $34K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,356 $34K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,152 $32K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 360 $29K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 227 $27K
80061 Lipid panel <1% 2,762 $23K
83880 <1% 1,913 $21K
84703 <1% 4,706 $20K
87420 <1% 975 $19K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 258 $19K
87807 <1% 1,423 $18K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 609 $18K
83021 <1% 2,063 $16K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,950 $14K
99219 <1% 307 $12K
G0379 Direct admission of patient for hospital observation care <1% 91 $12K
A9270 Non-covered item or service <1% 24,820 $11K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,377 $11K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 88 $10K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 210 $10K
85379 <1% 1,936 $10K
Q3014 Telehealth originating site facility fee <1% 581 $9K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 66 $9K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 285 $9K
82248 <1% 3,143 $8K
87040 <1% 1,758 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 205 $7K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 203 $6K
81025 <1% 1,013 $6K
96127 <1% 998 $6K
59025 Fetal non-stress test <1% 112 $6K
85027 <1% 1,435 $6K
94760 <1% 561 $5K
99203 Doctor's office visit, new patient (routine) <1% 124 $5K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 25 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 222 $4K
80055 <1% 155 $4K
72100 <1% 177 $4K
85730 <1% 2,193 $4K
85610 <1% 2,794 $3K
74022 <1% 57 $3K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 20 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 484 $3K
G0378 Hospital observation service, per hour <1% 86 $3K
80048 Basic metabolic panel (calcium, ionized) <1% 862 $3K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 13 $3K
86703 <1% 210 $3K
72125 Computed tomography, cervical spine; without contrast material <1% 104 $3K
81003 <1% 2,679 $3K
86787 <1% 169 $3K
87077 <1% 1,746 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 154 $2K
J7050 Infusion, normal saline solution, 250 cc <1% 708 $2K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 704 $2K
82607 <1% 312 $2K
99204 Doctor's office visit, new patient (more involved) <1% 24 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 28 $2K
87186 <1% 836 $2K
99406 <1% 325 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 113 $1K
83735 <1% 470 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 198 $1K
92587 <1% 29 $1K
82803 <1% 406 $1K
80305 <1% 112 $985.91
72110 <1% 20 $920.30
99215 Doctor's office visit, returning patient (complex) <1% 35 $913.82
77067 Screening mammography, bilateral, including computer-aided detection <1% 13 $690.27
85018 <1% 207 $637.10
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 15 $633.94
87176 <1% 510 $600.99
86592 <1% 131 $580.15
96376 <1% 137 $496.79
82950 <1% 90 $456.96
84702 <1% 46 $444.25
72050 <1% 17 $310.21
69210 <1% 15 $268.36
73560 <1% 53 $250.81
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 411 $249.27
87071 <1% 15 $236.92
J2270 Injection, morphine sulfate, up to 10 mg <1% 804 $231.50
J2704 Injection, propofol, 10 mg <1% 185 $229.09
82150 <1% 60 $224.66
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 67 $208.76
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 425 $199.19
94664 <1% 12 $199.15
72070 <1% 16 $181.76
36600 <1% 212 $155.56
83540 <1% 30 $122.86
90686 <1% 2,342 $105.69
J3010 Injection, fentanyl citrate, 0.1 mg <1% 114 $101.21
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 75 $86.37
82962 <1% 72 $82.77
73630 <1% 12 $71.43
86900 <1% 17 $16.17
77063 Screening digital breast tomosynthesis, bilateral <1% 13 $12.66
J1170 Injection, hydromorphone, up to 4 mg <1% 511 $8.69
86850 <1% 17 $8.07
86901 <1% 18 $8.07
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 54 $6.32
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 107 $0.95
J7609 Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg 0% 14 $0.00
90656 0% 89 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 41 $0.00
76377 0% 15 $0.00
91307 0% 14 $0.00
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 0% 16 $0.00
90670 0% 33 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 20 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHIATT, RACHEL (DIRECTOR, CBO)
Same official

Other billing entities under HIATT, RACHEL

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.